Retractable Technologies (NYSE:RVP) Research Coverage Started at StockNews.com

StockNews.com assumed coverage on shares of Retractable Technologies (NYSE:RVP) in a research report released on Saturday. The firm issued a hold rating on the stock.

Retractable Technologies Price Performance

Shares of NYSE:RVP opened at $0.70 on Friday. The company has a market capitalization of $20.99 million, a P/E ratio of -1.30 and a beta of 2.28. Retractable Technologies has a 1-year low of $0.56 and a 1-year high of $1.22. The firm’s 50 day simple moving average is $0.75 and its two-hundred day simple moving average is $0.73. The company has a debt-to-equity ratio of 0.01, a current ratio of 8.57 and a quick ratio of 5.92.

Institutional Investors Weigh In On Retractable Technologies

A hedge fund recently bought a new stake in Retractable Technologies stock. Wealthfront Advisers LLC acquired a new position in Retractable Technologies, Inc. (NYSE:RVP) in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 2,533,952 shares of the company’s stock, valued at approximately $1,748,000. Wealthfront Advisers LLC owned 8.46% of Retractable Technologies as of its most recent SEC filing. 7.58% of the stock is owned by institutional investors.

About Retractable Technologies

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.